Pharma Journalist -

Merck, known as MSD outside the U.S. and Canada, announced that it will acquire Verona Pharma plc in a $10 billion deal, strengthening its presence in the respiratory disease space. The…
Read More...

Indian pharmaceutical major Lupin Limited and pan-European drugmaker Zentiva Group have signed a license and supply agreement to commercialize Lupin’s biosimilar Certolizumab Pegol…
Read More...

AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI),announced an exclusive licensing agreement for IGI's lead…
Read More...

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that it has entered into a global licensing agreement with BeOne Medicines Ltd., a global oncology company, for multiple fully…
Read More...

Adcentrx Therapeutics, a clinical-stage biotech company specializing in Antibody-Drug Conjugate (ADC) therapies, announced that the U.S. Food and Drug Administration (FDA) has granted…
Read More...

Neuraxpharm Group, a leading European specialty pharmaceutical company focused on central nervous system (CNS) disorders, and Swedish R&D firm Dizlin Pharmaceuticals AB have…
Read More...

KalVista Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved EKTERLY (sebetralstat), a novel plasma kallikrein inhibitor, as the first and only…
Read More...

GSK plc has finalized its acquisition of efimosfermin alfa from Boston Pharmaceuticals, a promising investigational therapy targeting steatotic liver disease (SLD). Efimosfermin is a…
Read More...

Sagent Pharmaceuticals, a leading U.S. pharmaceutical provider, and China-based Qilu Pharmaceutical have entered a strategic partnership to commercialize a portfolio of complex…
Read More...

Chugai Pharmaceutical Co., Ltd., a major Japanese pharmaceutical company, and Singapore-based biotech firm Gero PTE. LTD. have announced a strategic joint research and license agreement…
Read More...